(NUE) Nucor - NYSE
Sector: Basic Materials | Industry: Steel | Exchange: NYSE (USA) | Market Cap: 55.530m USD | Total Return: 97.4% in 12m
Avg Turnover: 399M
EPS Trend: -84.5%
Qual. Beats: 1
Rev. Trend: -61.5%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Rs Leader, Idiosyncratic Leader, Confidence, Tailwind, Pullback 52w
Nucor Corporation is a major U.S.-based steel manufacturer operating through three business segments: Steel Mills, Steel Products, and Raw Materials. The Steel Mills segment produces hot-rolled, cold-rolled, and galvanized sheet steel, plate steel, structural products such as wide-flange beams and H-piling, and bar steel products, selling to service centers, fabricators, and manufacturers across the U.S., Canada, and Mexico while also engaging in steel trading and rebar distribution. The Steel Products segment fabricates a broad range of downstream items including steel joists and joist girders, steel decking, hollow structural section tubing, electrical conduit, cold-finished steel, fasteners, grating, wire mesh, metal building systems, insulated panels, and utility towers, and also operates a piling distribution business. The Raw Materials segment produces direct reduced iron (DRI), brokers ferrous and nonferrous metals and pig iron, supplies ferro-alloys, processes scrap metal, and participates in natural gas and industrial gas production. Founded in 1905 and headquartered in Charlotte, North Carolina, Nucor is widely recognized as the largest steel producer in the United States and is one of the leading operators of electric arc furnace (EAF) mini-mill technology, which relies primarily on recycled scrap steel as feedstock rather than traditional blast furnace methods.
- Hot-rolled steel prices fall on weak construction demand
- Scrap metal costs pressure steel mill margins
- Section 232 tariffs extended supporting domestic steel pricing
- New plate mill capacity ramp-up boosts production volumes
| Net Income: 2.33b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.01 > 1.0 |
| NWC/Revenue: 23.19% < 20% (prev 25.31%; Δ -2.12% < -1%) |
| CFO/TA 0.11 > 3% & CFO 3.76b > Net Income 2.33b |
| Net Debt (4.90b) to EBITDA (4.93b): 0.99 < 3 |
| Current Ratio: 2.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (229.3m) vs 12m ago -1.55% < -2% |
| Gross Margin: 13.98% > 18% (prev 10.46%; Δ 3.51% > 0.5%) |
| Asset Turnover: 97.14% > 50% (prev 87.69%; Δ 9.45% > 0%) |
| Interest Coverage Ratio: 25.33 > 6 (EBIT TTM 3.50b / Interest Expense TTM 138.0m) |
| A: 0.22 (Total Current Assets 12.1b - Total Current Liabilities 4.17b) / Total Assets 35.6b |
| B: 0.90 (Retained Earnings 32.1b / Total Assets 35.6b) |
| C: 0.10 (EBIT TTM 3.50b / Avg Total Assets 35.2b) |
| D: 1.64 (Book Value of Equity 21.5b / Total Liabilities 13.1b) |
| Altman-Z'' = 6.79 = AAA |
| DSRI: 1.07 (Receivables 3.57b/2.96b, Revenue 34.2b/30.4b) |
| GMI: 0.75 (GM 10.46% / 13.98%) |
| AQI: 0.95 (AQ_t 0.22 / AQ_t-1 0.24) |
| SGI: 1.12 (Revenue 34.2b / 30.4b) |
| TATA: -0.04 (NI 2.33b - CFO 3.76b) / TA 35.6b) |
| Beneish M = -3.14 (Cap -4..+1) = AA |
As of June 23, 2026, the stock is trading at USD 244.93 with a total of 1,270,341 shares traded. Over the past week, the price has changed by -8.04%, over one month by +5.57%, over three months by +53.01% and over the past year by +97.35%.
Current recommended Stop Loss: 234.10 (which is 4.4% or 1.3 ATR below the current price).
Nucor has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy NUE.
- StrongBuy: 5
- Buy: 5
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 257.8 | 5.3% |
P/E Trailing = 24.1895
P/E Forward = 15.748
P/S = 1.6256
P/B = 2.5885
P/EG = 5.2129
Revenue TTM = 34.2b USD
EBIT TTM = 3.50b USD
EBITDA TTM = 4.93b USD
Long Term Debt = 6.88b USD (from longTermDebt, last quarter)
Short Term Debt = 247.0m USD (from shortTermDebt, last quarter)
Debt = 7.38b USD (from shortLongTermDebtTotal, last quarter) + Leases 258.0m
Net Debt = 4.90b USD (calculated: Debt 7.38b - CCE 2.48b)
Enterprise Value = 60.4b USD (55.5b + Debt 7.38b - CCE 2.48b)
Interest Coverage Ratio = 25.33 (Ebit TTM 3.50b / Interest Expense TTM 138.0m)
EV/FCF = 113.6x (Enterprise Value 60.4b / FCF TTM 532.0m)
FCF Yield = 0.88% (FCF TTM 532.0m / Enterprise Value 60.4b)
FCF Margin = 1.56% (FCF TTM 532.0m / Revenue TTM 34.2b)
Net Margin = 6.82% (Net Income TTM 2.33b / Revenue TTM 34.2b)
Gross Margin = 13.98% ((Revenue TTM 34.2b - Cost of Revenue TTM 29.4b) / Revenue TTM)
Gross Margin QoQ = 15.81% (prev 11.21%)
Tobins Q-Ratio = 1.70 (Enterprise Value 60.4b / Total Assets 35.6b)
Interest Expense / Debt = 1.87% (Interest Expense 138.0m / Debt 7.38b)
Taxrate = 20.63% (697.0m / 3.38b)
NOPAT = 2.77b (EBIT 3.50b * (1 - 20.63%))
Current Ratio = 2.90 (Total Current Assets 12.1b / Total Current Liabilities 4.17b)
Debt / Equity = 0.34 (Debt 7.38b / totalStockholderEquity, last quarter 21.5b)
Debt / EBITDA = 0.99 (Net Debt 4.90b / EBITDA 4.93b)
Debt / FCF = 9.21 (Net Debt 4.90b / FCF TTM 532.0m)
Total Stockholder Equity = 20.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.63% (Net Income 2.33b / Total Assets 35.6b)
RoE = 11.16% (Net Income TTM 2.33b / Total Stockholder Equity 20.9b)
RoCE = 12.59% (EBIT 3.50b / Capital Employed (Equity 20.9b + L.T.Debt 6.88b))
RoIC = 9.25% (NOPAT 2.77b / Invested Capital 30.0b)
WACC = 9.52% (E(55.5b)/V(62.9b) * Re(10.59%) + D(7.38b)/V(62.9b) * Rd(1.87%) * (1-Tc(0.21)))
Discount Rate = 10.59% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.56 | Cagr: -3.29%
[DCF] Terminal Value 71.74% ; FCFF base≈527.6m ; Y1≈539.1m ; Y5≈591.3m
[DCF] Fair Price = 12.01 (EV 7.64b - Net Debt 4.90b = Equity 2.73b / Shares 227.7m; r=9.52% [WACC]; 5y FCF grow 2.11% → 2.50% )
EPS Correlation: -84.52 | EPS CAGR: -34.89% | SUE: 1.67 | # QB: 1
Revenue Correlation: -61.49 | Revenue CAGR: -4.40% | SUE: 2.54 | # QB: 1
EPS current Quarter (2026-06-30): EPS=4.44 | Chg30d=+6.89% | Revisions=+33% | Analysts=7
EPS next Quarter (2026-09-30): EPS=5.06 | Chg30d=+23.03% | Revisions=+33% | Analysts=5
EPS current Year (2026-12-31): EPS=16.24 | Chg30d=+11.76% | Revisions=+43% | GrowthEPS=+110.6% | GrowthRev=+18.4%
EPS next Year (2027-12-31): EPS=16.50 | Chg30d=+4.54% | Revisions=+25% | GrowthEPS=+1.6% | GrowthRev=+1.7%
[Analyst] Revisions Ratio: +43%